Outcome and prognostic markers in severe drug‐induced liver disease

@article{Bjrnsson2005OutcomeAP,
  title={Outcome and prognostic markers in severe drug‐induced liver disease},
  author={E. Bj{\"o}rnsson and R. Olsson},
  journal={Hepatology},
  year={2005},
  volume={42}
}
  • E. Björnsson, R. Olsson
  • Published 2005
  • Medicine
  • Hepatology
  • The combination of high aminotransferases (hepatocellular injury) and jaundice has been reported to lead to a mortality rate of 10% to 50% for different drugs, a phenomenon known as “Hy's rule.” However, Hy's rule has never been validated, and limited data exist on predictors for outcome in hepatocellular and other forms of drug‐induced liver disease. All reports of suspected hepatic adverse drug reactions received by the Swedish Adverse Drug Reactions Advisory Committee (1970‐2004) were… CONTINUE READING
    462 Citations
    Hospital Admissions for Drug-Induced Liver Injury: Clinical Features, Therapy, and Outcomes
    • 24
    Drug‐induced acute liver failure: Results of a U.S. multicenter, prospective study
    • 472
    • PDF
    Idiosyncratic drug-induced liver injury: an overview
    • 168
    The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice.
    • 116

    References

    SHOWING 1-10 OF 44 REFERENCES
    Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden
    • 113
    Fulminant hepatic failure: Summary of a workshop
    • 548
    Classification, etiology, and considerations of outcome in acute liver failure.
    • 159
    Severe Jaundice in Sweden in the New Millennium: Causes, Investigations, Treatment and Prognosis
    • 52